Andrew N. Wilner, MD June 26, 2023 The Consolidated Appropriations Act of 2023 mandates that all Drug Enforcement Administration (DEA)–registered physicians and healthcare providers complete a one-time, 8-hour CME training on managing and treating opioid and other substance abuse disorders. This requirement goes into effect on June 27, 2023. New DEA registrants must also comply. Veterinarians are exempt. A DEA registration...
Month: <span>July 2023</span>
Post
Helping GPs identify patients with persistent somatic symptoms earlier
by Leiden University Credit: Pixabay/CC0 Public Domain Medical psychologist Willeke Kitselaar has developed a model that helps identify patients with persistent somatic symptoms earlier, based on an extensive large medical database. “I advise GPs to ask patients to fill in a questionnaire about both physical and mental symptoms at an earlier stage.” Kitselaar’s Ph.D. defense takes...
Post
Sickle cell disease is 11 times more deadly than previously recorded, suggests study
by Institute for Health Metrics and Evaluation Credit: National Institutes of Health A new study suggests the number of deaths due to sickle cell disease is 11 times higher than what is indicated from mortality data sources alone. Sickle cell disease is not just underdiagnosed, but it also increases risk of infection and of death from...
Post
ADA: Glycemic control up with weekly icodec versus daily insulin glargine
by Elana Gotkine For adults with type 2 diabetes, glycemic control is significantly better with once-weekly icodec than once-daily insulin glargine U100, according to a study published online June 24 in the New England Journal of Medicine to coincide with the annual meeting of the American Diabetes Association, held from June 23 to 26 in San Diego....
Post
Q&A: Study of health records during the coronavirus pandemic assesses recommended care for Down syndrome patients
by Massachusetts General Hospital Total adherence rate to 5 select age-based AAP guidelines for individuals with Down syndrome in the MGH DSP from December 2018 to March 2022. Yellow lines denote the transition to virtual visits from April 2020 to June 2021 due to the COVID-19 pandemic and the timing of EHR integration intervention in July...
Post
GPs can play a key role in diagnosing vulval lichen sclerosus
by University of Bristol Credit: Unsplash/CC0 Public Domain Primary care professionals should think beyond thrush and genitourinary symptoms of menopause (GSM) when women present with vulval symptoms and consider the diagnosis of vulval lichen sclerosus (VLS), research led by the University of Bristol suggests. The work is published in the British Journal of General Practice. VLS...
Post
Higher doses of oral semaglutide improves blood sugar control and weight loss
by University of North Carolina Health Care Credit: Unsplash/CC0 Public Domain Diabetes is a progressive disease that affects one’s ability to control blood sugar levels. For many patients, the condition becomes more severe over time and blood sugar levels grow more difficult to manage. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, have granted patients more...
Post
Islet autoimmunity: Set of altered proteins may predict who will develop type 1 diabetes
by Pacific Northwest National Laboratory Scientists have taken an important step forward in predicting who will develop type 1 diabetes months before symptoms appear. In a paper published online on June 29 in Cell Reports Medicine, researchers at the Department of Energy’s Pacific Northwest National Laboratory and their colleagues identify a set of altered proteins that predict...
Post
Researchers discover secret of stem cells protecting the gastric mucosa
by Nara Institute of Science and Technology The gastric corpus, which is a major component of the glandular stomach, is composed of parietal, chief, pit, and neck cells. Each of these specialized epithelial cells play an important role in digestion, and they are continuously replenished by new ones which are formed via the differentiation of...
Post
Efficacy and safety of novel MDXX analogues in treating autism spectrum disorder
MARY ANN LIEBERT, INC./GENETIC ENGINEERING NEWS A new review in the peer-reviewed journal Psychedelic Medicine describes the complex pharmacology of methylenedioxy amphetamine analogues, or MDXX drugs, and how they may help treat autism spectrum disorder (ASD). Click here to read the article now. There are no approved pharmacotherapeutics for global symptoms of ASD. Drugs that have...